Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 116513
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.116513
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.116513
Table 2 Cohort balancing characteristics of patients before and after propensity score matching
| Perioperative vs postoperative treatment | Before PSM | Statistical volume | P value | After PSM (3:1) | Statistical volume | P value | ||
| Perioperative treatment (n = 532) | Postoperative treatment (n = 110) | Perioperative treatment (n = 330) | Postoperative treatment (n = 110) | |||||
| Age, years, median (IQR) | 54.0 (47.0-62.0) | 54.0 (47.0-62.8) | W = 28311.0 | 0.592 | 54.0 (47.0-62.0) | 54.0 (47.0-62.8) | W = 17514.5 | 0.582 |
| Male sex | 280 (52.6) | 70 (63.6) | χ2 = 4.452 | 0.035 | 216 (65.5) | 70 (63.6) | χ2 = 0.120 | 0.729 |
| ALT, median (IQR) | 24.0 (17.0-33.0) | 31.00 (20.3-35.0) | W = 23603.5 | 0.001 | 31.0 (20.0-36.0) | 31.0 (20.3-35.0) | W = 18114.5 | 0.976 |
| Extent of resection | χ2 = 0.068 | 0.794 | χ2 = 0.003 | 0.953 | ||||
| Major resection | 351 (66.0) | 74 (67.3) | 223 (67.6) | 74 (67.3) | ||||
| Minor resection | 181 (34.0) | 36 (32.7) | 107 (32.4) | 36 (32.7) | ||||
| Prophylaxis vs no prophylaxis | Before PSM | Statistical volume | P value | After PSM (1:1) | Statistical volume | P value | ||
| Prophylaxis (n = 876) | No prophylaxis (n = 835) | Prophylaxis (n = 680) | No prophylaxis (n = 680) | |||||
| Age, years, median (IQR) | 53.5 (46.0-62.0) | 54.0 (46.0-62.0) | W = 359007.5 | 0.510 | 54.0 (46.8-62.0) | 53.0 (45.0-62.0) | W = 233831.0 | 0.716 |
| Male sex | 330 (37.7) | 451 (54.0) | χ2 = 46.01 | < 0.001 | 319 (46.9) | 321 (47.2) | χ2 = 0.012 | 0.913 |
| ALT, median (IQR) | 23.0 (16.0-33.0) | 24.00 (16.0-33.0) | W = 356161.5 | 0.349 | 23.0 (15.0-33.0) | 24.0 (16.0-33.0) | W = 228588.5 | 0.718 |
| Extent of resection | χ2 = 33.227 | < 0.001 | χ2 = 1.196 | 0.274 | ||||
| Major resection | 423 (48.3) | 519 (62.2) | 373 (54.9) | 393 (57.8) | ||||
| Minor resection | 453 (51.7) | 316 (37.8) | 307 (45.2) | 287 (42.2) | ||||
| Treatment with magnesium isoglycyrrhizinate plus other liver protectants vs other liver protectants only | Before PSM | Statistical volume | P value | After PSM (1:3) | Statistical volume | P value | ||
| MgIG plus other liver protectants (n = 110) | Other liver protectants (n = 536) | MgIG plus other liver protectants (n = 110) | Other liver protectants (n = 330) | |||||
| Age, years, median (IQR) | 54.0 (47.0-62.8) | 54.0 (47.0-62.0) | W = 28753.0 | 0.684 | 54.0 (47.0-62.8) | 54.0 (48.0-62.0) | W = 17948.0 | 0.861 |
| Male sex | 70 (63.6) | 342 (63.8) | χ2 = 0.001 | 0.973 | 70 (63.6) | 192 (58.2) | χ2 = 1.019 | 0.313 |
| ALT, median (IQR) | 204.5 (141.3-428.3) | 216.5 (116.8-384.0) | W = 28763.5 | 0.688 | W = 17186.0 | 0.404 | ||
| Extent of resection | χ2 = 1.264 | 0.261 | χ2 = 0.165 | 0.685 | ||||
| Major resection | 74 (67.3) | 389 (72.6) | 74 (67.3) | 215 (65.2) | ||||
| Minor resection | 36 (32.7) | 147 (27.4) | 36 (32.7) | 115 (34.9) | ||||
- Citation: Xie ZQ, Wei JX, Zhong JY, Luo X, Zhuang HK, Ma XW, Wang QB, Tan WL, Wang BK, Chen YJ, Li CJ, Shang CZ. Effectiveness of magnesium isoglycyrrhizinate on perioperative hepatic function protection in patients undergoing hepatectomy. World J Gastroenterol 2026; 32(19): 116513
- URL: https://www.wjgnet.com/1007-9327/full/v32/i19/116513.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i19.116513